Harvard medical school in ethics quandary

New York Times, March 3, 2009

A full-blown movement by more than 200 Harvard Medical School students and sympathetic faculty is intent on exposing and curtailing drug industry influence in their classrooms and laboratories, as well as in Harvard's 17 affiliated teaching hospitals and institutes. They say they are concerned that the same money that helped build the school's world-class status may in fact be hurting its reputation and affecting its teaching. The students argue, for example, that Harvard should be embarrassed by the F grade it recently received from a national group that rates how well medical schools monitor and control drug industry money.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.